World's Best Scientists 2026 revealed!
Carlomaurizio Montecucco

Carlomaurizio Montecucco

D-Index & Metrics

Medicine

D-Index
83
Citations
27387
World Ranking
15531
National Ranking
604

Carlomaurizio Montecucco publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Carlomaurizio Montecucco sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 733 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Carlomaurizio Montecucco D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Carlomaurizio Montecucco sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Carlomaurizio Montecucco is affiliated with the University of Pavia in Italy. Their research primarily focuses on medicine, with significant contributions to the fields of rheumatology, pulmonary and respiratory medicine, pathology and forensic medicine, infectious diseases, and immunology. The scientist has a substantial body of work that includes 607 publications in medicine and related subfields.

Their research topics include:

  • Rheumatoid Arthritis Research and Therapies
  • Vasculitis and related conditions
  • Systemic Sclerosis and Related Diseases
  • Systemic Lupus Erythematosus Research
  • Autoimmune and Inflammatory Disorders Research
  • Inflammatory Myopathies and Dermatomyositis
  • COVID-19 Clinical Research Studies

Key recent publications by Carlomaurizio Montecucco include:

  • Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies, 2020, Annals of the Rheumatic Diseases
  • Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial, 2021, The Lancet
  • Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial, 2022, Nature Medicine
  • Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE), 2020, Microorganisms
  • Incidence of COVID-19 in Patients With Rheumatic Diseases Treated With Targeted Immunosuppressive Drugs: What Can We Learn From Observational Data?, 2020, Arthritis & Rheumatology

Carlomaurizio Montecucco frequently collaborates with several researchers, including:

  • Sara Monti
  • Serena Bugatti
  • Ludovico De Stefano
  • Lorenzo Cavagna
  • Paolo Delvino

The scientist's publications are often featured in notable venues such as:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • Clinical and Experimental Rheumatology
  • Frontiers in Medicine
  • Autoimmunity Reviews

Best Publications

  • Treating rheumatoid arthritis to target: recommendations of an international task force

    Josef S. Smolen;Daniel Aletaha;Johannes W J W Bijlsma;Ferdinand C Breedveld

  • Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)

    Maxime Dougados;Martin Soubrier;Anna Antunez;Peter Balint

  • Mapping and predicting mortality from systemic sclerosis

    Muriel Elhai;Christophe Meune;Marouane Boubaya;Jérôme Avouac

  • Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.

    Sara Monti;Silvia Balduzzi;Paolo Delvino;Elisa Bellis

  • Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse

    Carlo A. Scirè;Carlomaurizio Montecucco;Veronica Codullo;Oscar Epis

  • EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide.

    Raphaèle Seror;Simon J Bowman;Pilar Brito-Zeron;Elke Theander

  • Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative

    Francisca Sivera;Mariano Andres;Loreto Carmona;Alison Sr Kydd

  • Extended report: Evidence for treating rheumatoid arthritis to target: results of a systematic literature search

    Monika Schoels;Rachel Knevel;Daniel Aletaha;Johannes W J Bijlsma

  • Prednisone plus Methotrexate for Polymyalgia Rheumatica: A Randomized, Double-Blind, Placebo-Controlled Trial

    Roberto Caporali;Marco A. Cimmino;Gianfranco Ferraccioli;Roberto Gerli

  • Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis.

    Antonio Manzo;Samantha Paoletti;Maresa Carulli;Mark C Blades

  • Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

    Frances Humby;Frances Humby;Patrick Durez;Patrick Durez;Maya H Buch;Maya H Buch;Myles J Lewis;Myles J Lewis

  • Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial

    Gerd R Burmester;Xavier Mariette;Carlomaurizio Montecucco;Indalecio Monteagudo-Sáez

  • Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study

    Anna Moltó;Adrien Etcheto;Désirée van der Heijde;Robert Landewé

  • Sjögren's syndrome disease damage index and disease activity index: Scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients

    Claudio Vitali;Gianluigi Palombi;Chiara Baldini;Maurizio Benucci

  • Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients.

    Maurizio Pietrogrande;Salvatore De Vita;Anna Linda Zignego;Pietro Pioltelli

  • Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment

    Francesca Bobbio-Pallavicini;Claudia Alpini;Roberto Caporali;Stefano Avalle

  • Positive selection in autoimmunity: Abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis

    S. Albani;E. C. Keystone;J. L. Nelson;W. E R Ollier

  • Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study

    Amelia Ruffatti;Teresa Del Ross;Manuela Ciprian;Maria T Bertero

  • Comparison of clinical versus ultrasound-determined synovitis in juvenile idiopathic arthritis.

    Silvia Magni-Manzoni;Oscar Epis;Angelo Ravelli;Catherine Klersy

  • Tocilizumab for treatment of severe covid-19 patients: Preliminary results from smatteo covid19 registry (smacore)

    Marta Colaneri;Laura Bogliolo;Pietro Valsecchi;Paolo Sacchi

Frequent Co-Authors

Roberto Caporali
Roberto Caporali University of Milan
Guido Valesini
Guido Valesini Sapienza University of Rome
Stefano Bombardieri
Stefano Bombardieri University of Pisa
Maurizio Cutolo
Maurizio Cutolo University of Genoa
Walter Grassi
Walter Grassi Marche Polytechnic University
Marco Matucci-Cerinic
Marco Matucci-Cerinic University of Florence
Roberto Gerli
Roberto Gerli University of Perugia
Angela Tincani
Angela Tincani University of Brescia
Franco Franceschini
Franco Franceschini University of Brescia
Costantino Pitzalis
Costantino Pitzalis Queen Mary University of London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Expanding your education in healthcare doesn’t always mean following the traditional medical school path. Many students are exploring alternative and online options to quickly transition into rewarding healthcare roles. For example, those interested in nursing can consider an lpn school without teas test, which eliminates common standardized exam barriers and accelerates the entry process.

If you’re thinking about the administrative side of healthcare, you might explore healthcare administration programs that are offered online and in accelerated formats to quickly prepare you for leadership positions. Similarly, registered nurses looking to advance can bridge their credentials with an adn to np program, fast-tracking their route to becoming a nurse practitioner.

For those passionate about healthy living and wellness, a bachelor's in nutrition online can open doors to careers in dietetics, public health, and more. These flexible online degrees offer practical options for students seeking meaningful, in-demand positions in the healthcare sector.

Best Scientists Citing Carlomaurizio Montecucco

Trending Scientists

Recently Published Articles